Bacil Pharma Ltd share price logo

Bacil Pharma Ltd

BSE: 524516

Small Cap

Pharma Sector

₹20.92

+0.58

(+2.85%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Bacil Pharma shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

+102%

Searches for Bacil Pharma on INDmoney have increased by 102% over the last 30 days.

Bacil Pharma Stock Performance

as on September 16, 2026 at 5:43 pm IST

  • Day's Low

    Day's High

    ₹19.33
    ₹21.35
    downward going graph

    7.60%

    Downside

    2.06%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹10.65
    ₹61.80
    downward going graph

    49.09%

    Downside

    195.41%

    Upside

    downward going graph

Bacil Pharma share price movements today

Previous Close
₹20.34
Open
₹21.35
Volume
70.56K
Upper Circuit
₹21.35
Lower Circuit
₹19.33
Day's Low - High
₹19.33 - ₹21.35
52 Week Low - High
₹10.65 - ₹61.80

Bacil Pharma Historical Returns

1 Month Return
+ 63.11 %
3 Month Return
-49.68 %
1 Year Return
-41.74 %
3 Year Return
+ 214.37 %
5 Year Return
+ 238.44 %

Bacil Pharma Fundamentals

as on September 16, 2026 at 12:13 pm IST

Market Cap

₹29.19 Cr

Return on Equity (ROE)

6.21

PE Ratio (TTM)

27.69

Return on capital employed (ROCE)

3.93

Industry PE ratio

51.81

Beta (LTM)

0.38

P/B Ratio

2.69

Dividend Yield

0

PEG Ratio

-52.24

Quarterly Earnings Growth YOY

-102.99

EPS (TTM)

0

Book Value

0

Bacil Pharma Stock Valuation

as on September 16, 2026 at 12:13 pm IST

Bacil Pharma in the last 5 years

  • Overview

  • Trends

Lowest (-278.20x)

June 3, 2024

Today (27.69x)

September 11, 2026

Industry (51.81x)

September 11, 2026

Highest (109.83x)

October 6, 2025

LowHigh

Today’s Price to Earnings Ratio: 27.69x

Bacil Pharma Technical Analysis

Track how Bacil Pharma technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish3
Bullish7
Neutral5

Oscillators

Name

Value

Action

MACD level (12,26)
0
Bearish
CCI (20)
-666.67
Bullish
RSI (14)
53.94
Neutral
Momentum (10)
0
Neutral
ADI (14)
15.58
Neutral
Ultimate Oscillator (7,14,28)
78.71
Bullish

Moving Averages

Name

Value

Action

SMA (20)
20.92
Neutral
EMA (20)
20.92
Bullish
VWMA (20)
20.92
Neutral
SMA (50)
20.92
Bearish
EMA (50)
20.91
Bullish
SMA (200)
20.61
Bullish
EMA (200)
20.7
Bullish
KAMA (200)
20.92
Bullish
DEMA (200)
20.94
Bearish

Bacil Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bacil Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Bacil Pharma Ltd image
Bacil Pharma Ltd
NA29.1947.69%0.001NA
Concord Biotech Ltd image
Concord Biotech Ltd
BUY15,409.9711.25%0.502591,054
Beryl Drugs Ltd image
Beryl Drugs Ltd
NA11.7921.54%0.00-121
Natco Pharma Ltd image
Natco Pharma Ltd
HOLD14,671.79-3.06%0.541,3714,078
Parnax Lab Ltd image
Parnax Lab Ltd
NA142.2778.11%0.7311187
See all

Bacil Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Other Income
0.03
0.03
0.02
0.01
0.56
-
0.09
1
0.05
0.06
0.11
0.09
Total Income
0.03
0.03
0.02
0.01
0.56
-
0.09
1
0.05
0.06
0.11
0.09
Expenses
0.04
0.06
0.06
0.04
0.07
0.06
0.07
0.11
0.04
0.03
0.07
0.02
Operating Profit
-0.04
-0.06
-0.06
-0.04
-0.07
-0.06
-0.07
-0.11
-0.04
-0.03
-0.07
-0.02
Profit Before Interest, Tax and Depreciation
-0.01
-0.02
-0.04
-0.03
0.49
-0.06
0.02
0.89
0.02
0.04
0.04
0.07
Profit Before Tax
-0.01
-0.02
-0.04
-0.03
0.49
-0.06
0.02
0.89
0.02
0.04
0.04
0.07
Tax Paid
-
-
-
-
-
-
-
0.22
-
-
-0.58
0.08
Profit After Tax
-0.01
-0.02
-0.04
-0.03
0.48
-0.06
0.02
0.67
0.01
0.04
0.62
-0.02
Total Net profit including share of profit / Loss from associate company
-0.01
-0.02
-0.04
-0.03
0.48
-0.06
0.02
0.67
0.01
0.04
0.62
-0.02
EPS
-0.02
-0.04
-0.07
-0.06
0.82
-0.1
0.03
0.48
0.01
0.03
0.44
0.22
Actual EPS
-0.02
-0.04
-0.07
-0.06
0.82
-0.1
0.03
0.48
0.01
0.03
0.44
0.22
Adjusted EPS
-0.02
-0.04
-0.07
-0.06
0.82
-0.1
0.03
0.48
0.01
0.03
0.44
0.22
Diluted EPS
-0.02
-0.04
-0.07
-0.06
0.82
-0.1
0.03
0.48
0.01
0.03
0.44
0.22

Bacil Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Other Income
0.27
0.09
0.14
0.07
0.06
0.11
0.13
0.66
1.24
Total Income
0.27
0.09
0.14
0.07
0.06
0.11
0.13
0.66
1.24
Expenses
4.02
0.43
0.45
0.31
3.91
0.21
0.19
0.25
0.25
Operating Profit
-4.02
-0.43
-0.45
-0.31
-3.91
-0.21
-0.19
-0.25
-0.25
Profit Before Interest, Tax and Depreciation
-3.74
-0.33
-0.31
-0.23
-3.86
-0.1
-0.06
0.41
0.99
Depreciation
0.01
0.01
0.01
-
-
-
-
-
-
Profit Before Tax
-3.75
-0.34
-0.32
-0.23
-3.86
-0.1
-0.06
0.41
0.99
Tax Paid
-
-
-
-
-
-
-
-
-0.57
Profit After Tax
-3.75
-0.34
-0.32
-0.24
-3.86
-0.1
-0.06
0.4
1.56
Total Net profit including share of profit / Loss from associate company
-3.75
-0.34
-0.32
-0.24
-3.86
-0.1
-0.06
0.4
1.56
EPS
-6.37
-0.58
-0.54
-0.41
-6.55
-0.17
-0.1
0.69
1.11
Actual EPS
-6.37
-0.58
-0.54
-0.41
-6.55
-0.17
-0.1
0.69
1.11
Adjusted EPS
-6.37
-0.58
-0.54
-0.41
-6.55
-0.17
-0.1
0.69
1.11
Diluted EPS
-6.37
-0.58
-0.54
-0.41
-6.55
-0.17
-0.1
0.69
1.11

Bacil Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
0.06
-
1.44
-0.3
-0.38
-0.4
-4.01
-0.15
-
0.4
0.71
Cash Flow from Investing Activities
-2.71
0.03
-1.2
0.28
0.39
0.53
3.81
-0.12
0.08
0.34
-2.38
Cash Flow from Financing Activities
-
-
-
-0.16
-0.06
-0.07
0.33
0.06
-0.06
2.08
-0.62
Net Cash Flow
0.01
0.02
0.23
-0.18
-0.05
0.06
0.13
-0.2
0.01
2.82
-2.29

Bacil Pharma Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Jul 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
42.67%
42.67%
20.7%
10.6%
0.2%
0.2%
0.08%
0.08%
0.08%
0%
0%
Public
57.33%
57.33%
79.3%
89.4%
99.8%
99.8%
99.92%
99.92%
99.92%
100%
100%
Total Outstanding Shares
58,90,000
58,90,000
58,90,000
58,90,000
58,90,000
58,90,000
1,43,53,000
1,43,53,000
1,43,53,000
1,43,53,000
1,43,53,000
Total Shareholders
6,628
6,794
6,902
7,461
7,638
7,532
7,541
7,431
7,431
7,226
7,326

Bacil Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Bacil Pharma.

  • Bacil Pharma Ltd Earnings Results

    Bacil Pharma Ltd’s net profit fell -102.99% since last year same period to ₹0.02Cr in the Q1 2026-2027. On a quarterly growth basis, Bacil Pharma Ltd has generated -103.23% fall in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Bacil Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, Bacil Pharma stock has moved up by 63.1%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, Bacil Pharma has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 100.00% of holdings in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 50.8% return, outperforming this stock by 92.5%

About Bacil Pharma Ltd

Incorporated as a private limited company in Maharashtra in May 87 Bacil Pharma BPL was converted into a public limited company in Oct.90. The main business activity of the Company is Pharmaceutical.Bal Pharma is a fully integrated and leading Indian pharmaceutical company specialized in Prescription drugs Branded Formulations APIs Generic OTC products Intravenous Infusions and Bulk Drugs. Domestic operations are spread across pan India. The company has strong field force of 500 plus spread over various States and Districts. It has a strong distribution set up with Super Stockist in all the States and stockists for retail coverage. To augment the domestic market Companys operations are based on focused approach.MultiSpeciality division Vibrant specialises in various specialties like AntiInfectives Pain Management Respiratory Care Womens Health to name a few. Aziwin Ebay Balvibe MNF Ocium and Monogesic Plus Gel Innovative Pain Relieving Gel first time in India are some of the leading brands in the respective segments. Bal Vedics Division integrates modern medicine with herbal/ayurvedic preparation targeting specific conditions like Prostrate Enlargement Renal Calculi Male Infertility Women Health etc. Bal Pharma Institutional division is associated with the top Government bodies and Hospitals to extend its product range to the masses. Every area is well covered and supplied through there channel partners.Bal Pharma Unit 1 is a finished dosage facility for manufacturing Tablets and Capsules. Bal Pharma Unit 2 is involved in the manufacturing of APIs. A wellequipped RD laboratory a good Kilo laboratory and quality control facilities form the other spheres of activity here. Bal Pharma Unit 3 is a finished dosage facility for manufacturing Intravenous Fluids Ophthalmic Preparations Liquid Oral Preparations. BPL came out with a public issue of Rs 7 cr in Mar.94 to set up a plant at Vapi to manufacture bulk drugs like atenalol norfloxacin pefloxacin and ciprofloxacin. The company entered into a marketing arrangement with a distributor Kam Han Industries Hong Kong to export 50 of the production. Due to various reasons the civil works at Vapi were affected. However to avoid further delay in project implementation the company acquired from SICOM an existing bulk drug unit with necessary infrastructure and production facilities at Lote Parashuram near Ratnagiri..

Revenue: ₹0.00Cr as on June 2026 (Q1 FY27)
Net Profit: ₹0.02Cr as on June 2026 (Q1 FY27)
OrganisationBacil Pharma Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Bacil Pharma share price today?

Bacil Pharma share price today stands at ₹20.92 as on . Bacil Pharma share today touched a day high of ₹21.35 and a low of ₹19.33.

What is the 52 week high and 52 week low range for Bacil Pharma share?

Bacil Pharma touched a 52 week high of ₹61.8 and a 52 week low of ₹10.65. Bacil Pharma share price today i.e. is trending at ₹20.92, which is -66.15% down from its 52 week high and 96.43% up from its 52 week low.

What is Bacil Pharma's market capitalisation today?

Bacil Pharma market capitalisation is ₹29.19 Cr as on .

How to buy Bacil Pharma shares?

To buy Bacil Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 524516 or Bacil Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Bacil Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Bacil Pharma trading volume today?

Bacil Pharma trading volume is 70.56K as on . This means that 70.56K shares of Bacil Pharma were bought and sold on the stock market during today's trading session.